USPTO serial 87896266
ALL SYNDROMES KNOWN TO MAN EVALUATOR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 18, 2019
- Examiner
- LAPTER, ALAIN J
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with ALL SYNDROMES KNOWN TO MAN EVALUATOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Dana-Farber Cancer Institute, Inc.
Boston, MA
Other trademarks owned by Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc.
Boston, MA
Other trademarks owned by Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc.
Boston, MA
Other trademarks owned by Dana-Farber Cancer Institute, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Douglas R. Wolf
Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 038 | providing multiple user access to a platform for providing risk analysis, prediction, treatment, and management guidelines in the field of gene mutations | ACTIVE | Sep 3, 2016 |
| 042 | medical and scientific research services in the field of cancer; providing temporary use of non-downloadable software for providing risk analysis, prediction, treatment, and management guidelines in the field of gene mutations | ACTIVE | Sep 3, 2016 |
| 044 | providing information in the fields of cancer treatment and care; medical treatment services in the field of cancer; hospital services; health care services, namely providing risk analysis, prediction, treatment and disease management guidelines in the field of gene mutations | ACTIVE | Sep 3, 2016 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Dana-Farber Cancer Institute, Inc.
- Other trademarks owned by Dana-Farber Cancer Institute, Inc.
- Other trademarks owned by Dana-Farber Cancer Institute, Inc.
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ALL SYNDROMES KNOWN TO MAN EVALUATOR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 26, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Sep 26, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Sep 26, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 15, 2025 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jun 18, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 2, 2024 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Feb 27, 2024 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Feb 13, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 16, 2023 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Feb 10, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 10, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 18, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 2, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 2, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 13, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 25, 2019 | ALIE | ASSIGNED TO LIE | — |
| Feb 8, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 7, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 7, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 7, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2018 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 7, 2018 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 7, 2018 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 6, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| May 5, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 1, 2018 | NWAP | NEW APPLICATION ENTERED | — |